about
The Role of Neurotransmitters in Protection against Amyloid- β Toxicity by KiSS-1 Overexpression in SH-SY5Y NeuronsAnandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.Immunolocalization of Kisspeptin Associated with Amyloid-β Deposits in the Pons of an Alzheimer's Disease Patient.Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment.Cholesterol in Alzheimer's disease and other amyloidogenic disorders.Immunocytochemical staining of endogenous nuclear proteins with the HIS-1 anti-poly-histidine monoclonal antibody: a potential source of error in His-tagged protein detection.The amyloid-beta peptide binds to cyclin B1 and increases human cyclin-dependent kinase-1 activity.The neuronal nicotinic acetylcholine receptor alpha 2 subunit gene promoter is activated by the Brn-3b POU family transcription factor and not by Brn-3a or Brn-3c.Inhibition of catalase activity with 3-amino-triazole enhances the cytotoxicity of the Alzheimer's amyloid-beta peptide.Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide.Polymorphism of amyloid-beta fibrils and its effects on human erythrocyte catalase binding.The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy.Human islet amyloid polypeptide fibril binding to catalase: a transmission electron microscopy and microplate study.Production and utilization of monoclonal antibodies to human/rat corticotrophin-releasing factor-41Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitroEffect of noradrenaline and gamma-aminobutyric acid on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitroCorticotrophin-releasing factor-41 in the human and rat-utility of a highly sensitive enzyme amplified immunometric assayThe effects of rat corticotrophin-releasing factor-41 Peptide fragments on bioassay and immunoassay determination of corticotrophin-releasing factor-41 levelsThe formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA
P50
Q33711261-85C0CB32-541B-4995-A3FA-A7BFF894178AQ34154777-B46EB3E9-5291-4C3C-904F-9F3B6B32930EQ35623440-4E341AA8-EDAB-4BAC-888C-2BFA06D8D48FQ35666080-037AA7CC-B771-4B54-84A0-E6984A650060Q37705128-0F90DDAA-AC97-4ABE-8964-2214502BBD2FQ38994401-E26D0C8F-37FA-4024-B295-66A2AB62CB4AQ40737620-5155765E-83C5-4DC5-B566-5DF0D5AC5A78Q41333925-2C61782A-A4B5-44D9-B9C7-6E2A5533B800Q43877810-615AA187-F0A0-41FC-BF73-3C20E41BA8DDQ46034908-49A95E10-74EC-4C66-9C4C-7313C6B5466DQ46223907-9D91D1FE-F8E4-4A17-97A8-1BD8ABBB408FQ52400364-4EFD6C77-FAD9-43D6-8850-C0734C32F6D0Q55080889-6EDADFB2-352C-4E48-9324-D6C10B1F880BQ68616418-C1ABA42D-7E4C-45E3-835F-A4462CD53697Q69375458-5001B7B0-5B7A-4DC1-997B-C062CB5AA336Q69788177-2ABFCE9C-4371-4AA6-9E57-5CAD82AE68C7Q83344614-3F650F94-025B-469B-BD26-F39B654F361EQ83344621-940BE564-D290-4563-A819-B1AA7322F7B1Q92562491-145CCE88-A55F-4F53-9B2B-18537495B7E0
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Milton NG
@ast
Milton NG
@es
Milton NG
@nl
Nathaniel G. Milton
@en
type
label
Milton NG
@ast
Milton NG
@es
Milton NG
@nl
Nathaniel G. Milton
@en
altLabel
Milton NG
@en
prefLabel
Milton NG
@ast
Milton NG
@es
Milton NG
@nl
Nathaniel G. Milton
@en
P108
P108
P31
P496
0000-0002-7431-9060